TransCode TherapeuticsOffering
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
Bringing Trust to the $120 billion Skincare Industry
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.
our business and investment operations:- Preservation of Capital ...
to capital through the ability to raise up to $75 million, but also a greater ... provisions, hindering the issuer’s future capital raising activities. Alabama’s ...
Oil and Gas Investment Opportunity – High ROI, Tax Benefits & Cash Flow